Checking AUPH unusual options activity helps you spot when traders are making outsized bets on Aurinia Pharmaceuticals Inc before the broader market catches on. Aurinia Pharmaceuticals Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor AUPH unusual options activity today and surface the prints that deserve a second look.
Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching AUPH unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking AUPH unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and AUPH unusual options flow data becomes especially valuable around earnings, product launches, and macro events.
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.
Catalysts rarely arrive without a footprint, and AUPH unusual options activity is often where that footprint shows up first. Our scanner tracks Aurinia Pharmaceuticals Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at AUPH unusual options volume on the call side or chasing put sweeps, Aurinia Pharmaceuticals Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.
